Fabio Bagnoli PhD

Dr. Fabio Bagnoli is the discovery project leader of research & development programs at GSK. Research conducted by Fabio led to the development of various vaccine candidates as well as the filing of several patents and publications on several human pathogens published in important peer-review journals. He has served as editor of several publications and as coordinator of an industrial-academic effort on human organotypic models. He holds a PhD in Molecular and Cellular Microbiology from the University of Padova and conducted post-doctoral studies at Stanford University under the guidance of Dr. Stanley Falkow and Dr. Manuel Amieva.